Dynatrace Breaks Out as Buying Pressure Builds

Technology continues to command an outsized share of market leadership, making it increasingly important to distinguish stocks with genuine buying support from those simply riding sector momentum. One name that stands out is Dynatrace (DT), which spent much of the early year consolidating in the high $30s before breaking out in late spring and establishing a sustained pattern of higher highs and higher lows. The shares have since pushed to fresh 52-week highs and recently cleared multi-year overhead resistance, while its On-Balance Volume (OBV) indicator has been trending higher alongside price. That combination suggests buying pressure is consistently outweighing selling pressure, providing technical evidence that DT’s advance has participation behind it rather than relying on price momentum alone.

👀 The money is moving—and most traders may be watching the wrong stocks! Join Blane Markham, FREE tomorrow at 1 PM to see what’s catching his attention. 👉 Register now!

With DT trading around $65, buying shares outright offers a straightforward way to participate, but the options market presents another route worth considering. Rather than paying for a call option loaded with time value, I’d look at an in-the-money call debit spread, a defined-risk strategy that can provide bullish exposure with more flexibility around where the stock finishes at expiration. One example offers 56.2% profit potential if DT finishes at expiration up, flat, or down as much as 10.0%, with an entry cost of just $320; the outcome remains conditional on the spread’s specific strike prices, expiration, and final stock price, and the initial debit is at risk.

Finding attractive setups is one challenge; turning them into a consistent, well-researched trading process while building another potential income stream is another. With my Weekly Profit Opportunity Newsletter, you get my top setup each week, including a full video breakdown, technical analysis, and the specific trade approach I’d consider. Click Here to start your $1 first-month trial today and see how a disciplined, research-driven approach can help you evaluate the market’s next opportunities.

Wishing You the Best in Investing Success,